Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome-Reference-Cited by-同舟云学术

Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome

Author:

Deal Cheri L.¹,Tony Michèle²,Höybye Charlotte³,Allen David B.⁴,Tauber Maïthé⁵,Christiansen Jens Sandahl⁶,

Affiliation:

1. Research Center and Department of Pediatrics (C.L.D.), Centre Hospitalier Universitaire Sainte-Justine, Montréal, Québec, Canada H3T 1C5

2. Department of Health Administration (M.To.), Université de Montréal, Montréal, Québec, Canada H3N 1X7

3. Department of Endocrinology, Metabolism, and Diabetology (C.H.), Karolinska University Hospital, SE-17176 Stockholm, Sweden

4. Department of Pediatrics (D.B.A.), University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53705

5. Department of Endocrinology (M.Ta.), Hôpital des Enfants and Université Paul Sabatier, 31059 Toulouse, Cedex 9, France

6. Department of Endocrinology and Diabetes (J.S.C.), Aarhus University Hospital, DK-8000 Aarhus, Denmark

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

Reference145 articles.

1. Prader-Willi syndrome;Cassidy;Genet Med,2012

5. Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children;Tauber;Horm Res,2000

Cited by 292 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献